A Smart + Strong Site
Subscribe to:
POZ magazine
Am I Infected?
(A Guide to Testing for HIV)
en español

When should you get tested and is the test result accurate?

There is a "window period" which is the time it takes the body to produce antibodies after HIV infection has begun. For the vast majority of those who will test positive, antibodies to HIV will develop within 4-6 weeks after exposure. Some will take a little longer to develop antibodies. To make certain that you receive a reliable test result, it's necessary to wait at least three months (13 weeks) after your last possible exposure to the virus before being tested.

Getting tested before three months may result in an unclear result or a false negative. Some testing centers may recommend testing again at six months. More than 99 percent of those who are going to seroconvert will do so within three months (seroconversion is the development of detectable antibodies to HIV in the blood as a result of infection.) It's extremely rare for seroconversion to take more than six months to develop detectable antibodies.

No diagnostic test will ever be 100 percent reliable, but if you test negative at the appropriate time (i.e., 13 weeks after possible exposure to the virus), you can consider that to be a dependable confirmation that you are HIV negative.

back next

Last Revised: June 04, 2013

This content is written by the POZ and AIDSmeds editorial team. For more information, please visit our "About Us" page.

Prevention updates
Significant Drop in Global New HIV Cases and AIDS Deaths

New Vaccine Clears AIDS-Causing Virus in Monkeys

PrEP Adherence Curbs HIV Transmission in Straight Couples

Partner Violence May Reduce Female-Initiated HIV Prevention

Circumcision Program in South African Town Reduces HIV Rates

PrEP Did Not Increase Sexual Risks in Study of Gay Men

HIV Vaccine Based on Whole Virus Completes Phase I Trial

U.S. Revises Guidelines for Occupational HIV Exposure

Negative Gay Men Consider Viral Load Before Unprotected Sex

Lottery Incentives Slash HIV Risk for Women in Lesotho

Trial of PrEP in Drug Users Called Into Question

Altered Testing Methods Can ID HIV Earlier, May Help in Prevention

Global Report on Treatment as Prevention Urges Local Planning

Pre-Exposure Prophylaxis Protects Drug Users Against HIV

U.K. Throws Weight Behind Treatment as Prevention Model

Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples

Interim PrEP Recs Now Available for At-Risk Heterosexuals

Novel Vaginal HIV Microbicide Ring Enters Large-Scale Clinical Trial

What Do U.S. Women at Risk for HIV Think About PrEP?

Engagement in U.S. HIV Care: Problem Even Worse Among Blacks, Young People

> More Treatment News

Search for news stories about this topic

Lesson Index
Collapse All | Up One Level

Tell us what you think
Have you visited your health care provider within the last 4 months?

The Power of Prevention

more surveys
[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.